Clinic
Revere Health PC
Revere Health PC was paid $23.91M by Medicaid between Jan 2018 and Dec 2024, across 355 billing codes. Its largest line is 99214, doctor's office visit, returning patient (more involved) — 34% of everything it billed.
33Billing provider infoREVERE HEALTH PC
PROVO, UT 84604
PROVO, UT 84604
33aNPI1093764805assigned 05/09/2006
33bProvider typeMulti-Specialty Clinic/Center
28Total paid$23.91M
24GClaims585,484
24DCodes billed355
24AFirst – last monthJan 2018 – Dec 2024
Compared with peers
Next to other Multi-Specialty Clinic/Center providers in Utah
Rank by total paid#1 of 26
Median peer was paid$102K
This provider vs. median234×
Peers share this provider's primary NPPES type and state. Size alone says nothing about billing quality: a big agency or a hospital system is expected to sit far above the median.
Box 24A · Dates of service
Paid by month
Paid that monthNov–Dec 2024: claims still arriving when the file was cut, so these months run low for every provider
By year, as a table
| Year | Claims | Paid | |
|---|---|---|---|
| 2018 | 33,010 | $1.36M | |
| 2019 | 37,685 | $1.71M | |
| 2020 | 37,359 | $1.73M | |
| 2021 | 73,256 | $3.66M | |
| 2022 | 79,174 | $4.23M | |
| 2023 | 157,185 | $5.98M | |
| 2024incomplete | 167,815 | $5.24M |
Box 24 · Service lines
What it billed for
| Code | Service | Share | Claims | Bene. records | Paid |
|---|---|---|---|---|---|
| 99214 | Doctor's office visit, returning patient (more involved)Office or other outpatient visit for the evaluation and management of an established patient, moderate complexity | 34% | 133,130 | 111,453 | $8.21M |
| 99213 | Doctor's office visit, returning patient (routine)Office or other outpatient visit for the evaluation and management of an established patient, low complexity | 24% | 116,291 | 100,851 | $5.65M |
| 99232 | Hospital visit by a doctor, follow-up daySubsequent hospital care, per day, moderate complexity | 3.6% | 23,755 | 7,809 | $866K |
| 96413 | Chemotherapy administration, intravenous infusion; up to 1 hour, single or initial substance | 3.5% | 1,116 | 803 | $843K |
| 99203 | Doctor's office visit, new patient (routine)Office or other outpatient visit for the evaluation and management of a new patient, low complexity | 2.8% | 11,113 | 9,982 | $669K |
| 99204 | Doctor's office visit, new patient (more involved)Office or other outpatient visit for the evaluation and management of a new patient, moderate complexity | 2.4% | 6,631 | 6,232 | $572K |
| 59400 | Routine obstetric care including antepartum care, vaginal delivery, and postpartum care | 1.6% | 232 | 222 | $372K |
| 99233 | Hospital visit by a doctor, follow-up day (complex)Prolong inpt eval add15 m | 1.3% | 5,882 | 1,271 | $305K |
| 97110 | Therapeutic procedure, each 15 minutes; therapeutic exercises to develop strength and endurance, flexibility and range of motion | 1.0% | 9,077 | 3,457 | $244K |
| 99215 | Doctor's office visit, returning patient (complex)Prolong outpt/office vis | <1% | 3,210 | 2,887 | $233K |
| 90960 | End-stage renal disease related services monthly, for patients 20 years and older, with 4 or more face-to-face visits | <1% | 3,989 | 3,318 | $213K |
| 93306 | Echocardiography, transthoracic, real-time with image documentation, with and without Doppler, complete | <1% | 3,288 | 3,046 | $211K |
343 more codes
| 99391 | Periodic comprehensive preventive medicine reevaluation, established patient, infant (under 1 year) | <1% | 2,962 | $191K |
| 99231 | Subsequent hospital care, per day, straightforward or low complexity | <1% | 9,137 | $184K |
| 43239 | Esophagogastroduodenoscopy, flexible, transoral; with biopsy, single or multiple | <1% | 1,150 | $173K |
| 36415 | Collection of venous blood by venipuncture | <1% | 27,141 | $172K |
| J0585 | Injection, onabotulinumtoxina, 1 unit | <1% | 792 | $163K |
| 74177 | Computed tomography, abdomen and pelvis; with contrast material | <1% | 2,779 | $146K |
| 95810 | Polysomnography; sleep staging with 4 or more additional parameters | <1% | 556 | $133K |
| 90471 | Immunization administration (includes percutaneous, intradermal, subcutaneous, or intramuscular injections), 1 vaccine | <1% | 9,159 | $130K |
| 99222 | Initial hospital care, per day, moderate complexity | <1% | 1,513 | $105K |
| 88305 | Level IV - Surgical pathology, gross and microscopic examination | <1% | 2,094 | $104K |
| 80050 | General health panel | <1% | 3,192 | $95K |
| 45385 | Colonoscopy, flexible; with removal of tumor(s), polyp(s), or other lesion(s) | <1% | 375 | $93K |
| 43235 | <1% | 599 | $86K | |
| 45380 | Colonoscopy, flexible; with biopsy, single or multiple | <1% | 396 | $85K |
| 45378 | Colonoscopy, flexible; diagnostic, including collection of specimen(s) | <1% | 442 | $85K |
| 71275 | Computed tomographic angiography, chest, with contrast material | <1% | 507 | $84K |
| 99223 | Prolong inpt eval add15 m | <1% | 819 | $81K |
| 73721 | Magnetic resonance imaging, any joint of lower extremity; without contrast material | <1% | 663 | $79K |
| 99392 | Periodic comprehensive preventive medicine reevaluation, established patient, early childhood (1-4 years) | <1% | 1,478 | $78K |
| 72148 | Magnetic resonance imaging, lumbar spine; without contrast material | <1% | 759 | $78K |
| 43249 | <1% | 285 | $77K | |
| 93229 | <1% | 193 | $75K | |
| 70553 | Magnetic resonance imaging, brain; without contrast material, followed by contrast material and further sequences | <1% | 432 | $74K |
| 99394 | Periodic comprehensive preventive medicine reevaluation, established patient, adolescent (12-17 years) | <1% | 1,125 | $72K |
| 99205 | Prolong outpt/office vis | <1% | 719 | $72K |
| 71045 | Radiologic examination, chest; single view | <1% | 8,727 | $71K |
| 99395 | Periodic comprehensive preventive medicine reevaluation, established patient, 18-39 years | <1% | 1,258 | $70K |
| 99393 | Periodic comprehensive preventive medicine reevaluation, established patient, late childhood (5-11 years) | <1% | 1,022 | $65K |
| 90961 | <1% | 945 | $64K | |
| 80053 | Comprehensive metabolic panel | <1% | 7,455 | $62K |
| 17110 | <1% | 881 | $61K | |
| 90834 | Psychotherapy session, about 45 minutes | <1% | 685 | $53K |
| 99396 | Periodic comprehensive preventive medicine reevaluation, established patient, 40-64 years | <1% | 737 | $48K |
| 80061 | Lipid panel | <1% | 4,123 | $46K |
| 96365 | Intravenous infusion, for therapy, prophylaxis, or diagnosis; initial, up to 1 hour | <1% | 634 | $45K |
| 70450 | Computed tomography, head or brain; without contrast material | <1% | 1,323 | $45K |
| 87880 | Infectious agent antigen detection by immunoassay; Streptococcus, group A | <1% | 3,794 | $44K |
| 95004 | Percutaneous tests with allergenic extracts, immediate type reaction | <1% | 1,060 | $41K |
| 99212 | Office or other outpatient visit for the evaluation and management of an established patient, straightforward | <1% | 1,302 | $39K |
| 73221 | <1% | 324 | $39K | |
| 82306 | Vitamin D; 25 hydroxy, includes fraction(s), if performed | <1% | 2,302 | $39K |
| 96372 | Therapeutic, prophylactic, or diagnostic injection; subcutaneous or intramuscular | <1% | 4,876 | $38K |
| 95811 | <1% | 156 | $38K | |
| 83036 | Hemoglobin; glycosylated (A1C) | <1% | 5,086 | $37K |
| 85025 | Blood count; complete (CBC), automated, and automated differential WBC count | <1% | 7,925 | $36K |
| 76805 | Ultrasound, pregnant uterus, real time with image documentation, fetal and maternal evaluation | <1% | 543 | $34K |
| 70551 | Magnetic resonance imaging, brain; without contrast material | <1% | 249 | $34K |
| 74176 | Computed tomography, abdomen and pelvis; without contrast material | <1% | 532 | $33K |
| 76856 | Ultrasound, pelvic (nonobstetric), real time with image documentation; complete | <1% | 786 | $33K |
| 71046 | Radiologic examination, chest; 2 views | <1% | 2,685 | $31K |
| 64615 | <1% | 535 | $31K | |
| 72141 | <1% | 282 | $31K | |
| 84443 | Thyroid stimulating hormone (TSH) | <1% | 2,424 | $31K |
| 76830 | Ultrasound, transvaginal | <1% | 728 | $31K |
| 95886 | <1% | 288 | $30K | |
| 97161 | <1% | 707 | $29K | |
| 99051 | <1% | 3,700 | $29K | |
| 87635 | Infectious agent detection by nucleic acid; SARS-CoV-2 (COVID-19), amplified probe | <1% | 545 | $28K |
| 90472 | Immunization administration, each additional vaccine (list separately) | <1% | 3,079 | $26K |
| 76705 | Ultrasound, abdominal, real time with image documentation; limited | <1% | 772 | $26K |
| 76642 | <1% | 521 | $26K | |
| 93971 | <1% | 513 | $25K | |
| 99152 | <1% | 1,099 | $25K | |
| 76801 | <1% | 398 | $24K | |
| 20610 | <1% | 1,057 | $24K | |
| 71250 | <1% | 218 | $24K | |
| 90837 | Psychotherapy session, about an hour | <1% | 293 | $24K |
| 82728 | <1% | 1,992 | $24K | |
| 87811 | Infectious agent antigen detection by immunoassay; SARS-CoV-2 (COVID-19) | <1% | 877 | $22K |
| 99202 | Office or other outpatient visit for the evaluation and management of a new patient, straightforward | <1% | 722 | $22K |
| 82607 | <1% | 1,760 | $21K | |
| 76816 | Ultrasound, pregnant uterus, real time with image documentation, follow-up | <1% | 507 | $21K |
| 99238 | Hospital discharge day management, 30 minutes or less | <1% | 372 | $20K |
| 42820 | Tonsillectomy and adenoidectomy; younger than age 12 | <1% | 106 | $19K |
| 94729 | <1% | 512 | $19K | |
| 99385 | <1% | 252 | $19K | |
| 87491 | Infectious agent detection by nucleic acid; Chlamydia trachomatis, amplified probe | <1% | 509 | $19K |
| 87591 | Infectious agent detection by nucleic acid; Neisseria gonorrhoeae, amplified probe | <1% | 509 | $18K |
| G0500 | Moderate sedation services provided by the same physician or other qualified health care professional performing a gastrointestinal endoscopic service that sedation supports, requiring the presence of an independent trained observer to assist in the monitoring of the patient's level of consciousness and physiological status; initial 15 minutes of intra-service time; patient age 5 years or older (additional time may be reported with 99153, as appropriate) | <1% | 860 | $17K |
| G2211 | Visit complexity inherent to evaluation and management associated with medical care services that serve as the continuing focal point for all needed health care services and/or with medical care services that are part of ongoing care related to a patient's single, serious condition or a complex condition. (add-on code, list separately in addition to office/outpatient evaluation and management visit, new or established) | <1% | 17,708 | $17K |
| 84439 | <1% | 2,957 | $17K | |
| 87502 | Infectious agent detection by nucleic acid, influenza virus, for multiple types or subtypes, includes all targets | <1% | 393 | $17K |
| 84403 | <1% | 632 | $16K | |
| 95117 | <1% | 2,482 | $16K | |
| 87651 | Infectious agent detection by nucleic acid; Streptococcus, group A, amplified probe | <1% | 592 | $16K |
| 73562 | <1% | 1,230 | $16K | |
| 73630 | <1% | 1,275 | $15K | |
| 87428 | <1% | 356 | $15K | |
| 93970 | <1% | 199 | $15K | |
| 73110 | <1% | 1,068 | $14K | |
| 77067 | Screening mammography, bilateral, including computer-aided detection | <1% | 793 | $14K |
| 83550 | <1% | 1,739 | $14K | |
| 99460 | <1% | 197 | $13K | |
| 83013 | <1% | 195 | $13K | |
| 97140 | Manual therapy techniques, each 15 minutes (e.g., mobilization/manipulation, manual lymphatic drainage) | <1% | 2,377 | $13K |
| 72125 | Computed tomography, cervical spine; without contrast material | <1% | 331 | $12K |
| 73610 | <1% | 1,090 | $12K | |
| 90715 | <1% | 679 | $12K | |
| 94060 | <1% | 524 | $12K | |
| 76700 | Ultrasound, abdominal, real time with image documentation; complete | <1% | 226 | $11K |
| 71260 | Computed tomography, thorax, diagnostic; with contrast material | <1% | 359 | $11K |
| 93000 | <1% | 1,445 | $11K | |
| 87426 | Infectious agent antigen detection, SARS-CoV-2 (COVID-19) | <1% | 496 | $11K |
| 78815 | Positron emission tomography (PET) for limited area imaging | <1% | 13 | $11K |
| 73030 | <1% | 1,001 | $11K | |
| 90686 | <1% | 2,436 | $11K | |
| 99308 | Subsequent nursing facility care, per day, straightforward | <1% | 543 | $11K |
| 70496 | <1% | 91 | $11K | |
| 81003 | <1% | 4,605 | $11K | |
| 70498 | <1% | 91 | $11K | |
| 87804 | Infectious agent antigen detection by immunoassay; Influenza, each type | <1% | 1,045 | $10K |
| 76536 | <1% | 281 | $10K | |
| 74018 | <1% | 887 | $10K | |
| 73502 | <1% | 688 | $10K | |
| 73130 | <1% | 844 | $9K | |
| 72100 | <1% | 622 | $9K | |
| 59410 | <1% | 13 | $9K | |
| 70486 | <1% | 100 | $9K | |
| 58300 | <1% | 136 | $9K | |
| G0121 | Colorectal cancer screening; colonoscopy on individual not meeting criteria for high risk | <1% | 44 | $9K |
| 84144 | <1% | 438 | $9K | |
| 83540 | <1% | 1,745 | $9K | |
| 83970 | <1% | 216 | $9K | |
| 59426 | <1% | 13 | $8K | |
| 82670 | <1% | 328 | $8K | |
| 81025 | <1% | 1,062 | $7K | |
| 73140 | <1% | 651 | $7K | |
| 92014 | Ophthalmological services: medical examination and evaluation, comprehensive, established patient | <1% | 167 | $7K |
| 80074 | <1% | 215 | $7K | |
| 76770 | <1% | 183 | $7K | |
| 86140 | <1% | 1,230 | $7K | |
| 97014 | <1% | 2,294 | $7K | |
| 92004 | Ophthalmological services: medical examination and evaluation, comprehensive, new patient | <1% | 135 | $7K |
| 99221 | <1% | 112 | $6K | |
| 76815 | Ultrasound, pregnant uterus, real time with image documentation, limited | <1% | 185 | $6K |
| 99384 | <1% | 96 | $6K | |
| G0439 | Annual wellness visit, includes a personalized prevention plan of service (pps), subsequent visit | <1% | 764 | $6K |
| 87389 | Infectious agent antigen detection by immunoassay technique, HIV-1 antigen with HIV-1 and HIV-2 antibodies | <1% | 406 | $6K |
| A9585 | Injection, gadobutrol, 0.1 ml | <1% | 464 | $6K |
| 84481 | <1% | 416 | $6K | |
| 83001 | <1% | 335 | $6K | |
| J3301 | Injection, triamcinolone acetonide, not otherwise specified, 10 mg | <1% | 2,055 | $6K |
| 97530 | Therapeutic activities, direct patient contact, each 15 minutes | <1% | 435 | $6K |
| 95913 | <1% | 22 | $6K | |
| 73080 | <1% | 427 | $6K | |
| 84153 | <1% | 338 | $6K | |
| Q9967 | Low osmolar contrast material, 300-399 mg/ml iodine concentration, per ml | <1% | 1,638 | $6K |
| 87653 | <1% | 171 | $6K | |
| 82043 | <1% | 995 | $5K | |
| 85027 | <1% | 1,077 | $5K | |
| 73564 | <1% | 419 | $5K | |
| 96367 | <1% | 231 | $5K | |
| 90962 | <1% | 129 | $5K | |
| 90656 | <1% | 454 | $5K | |
| 84270 | <1% | 322 | $5K | |
| 17000 | <1% | 229 | $5K | |
| 88321 | <1% | 91 | $5K | |
| 91320 | <1% | 50 | $4K | |
| 11102 | <1% | 96 | $4K | |
| 90651 | <1% | 320 | $4K | |
| 80305 | <1% | 467 | $4K | |
| 96415 | <1% | 211 | $4K | |
| J1050 | Injection, medroxyprogesterone acetate, 1 mg | <1% | 233 | $4K |
| 82570 | <1% | 1,215 | $4K | |
| 96127 | <1% | 2,087 | $4K | |
| 80048 | Basic metabolic panel (calcium, ionized) | <1% | 689 | $4K |
| 92557 | <1% | 174 | $4K | |
| 83735 | <1% | 598 | $4K | |
| 69210 | <1% | 249 | $4K | |
| 94727 | <1% | 506 | $3K | |
| 93356 | <1% | 132 | $3K | |
| 78431 | <1% | 95 | $3K | |
| 90461 | <1% | 309 | $3K | |
| 80081 | <1% | 51 | $3K | |
| 93228 | <1% | 204 | $3K | |
| A4590 | Special casting material (e.g., fiberglass) | <1% | 127 | $3K |
| 82746 | <1% | 232 | $3K | |
| 74183 | <1% | 13 | $3K | |
| 73590 | <1% | 259 | $3K | |
| 80069 | <1% | 517 | $3K | |
| 0012A | <1% | 337 | $3K | |
| 85652 | <1% | 1,018 | $3K | |
| 97802 | <1% | 50 | $3K | |
| 97010 | <1% | 4,764 | $3K | |
| 83002 | <1% | 166 | $3K | |
| 84146 | <1% | 141 | $3K | |
| 92567 | <1% | 302 | $3K | |
| J1750 | Injection, iron dextran, 50 mg | <1% | 26 | $3K |
| 72040 | <1% | 177 | $3K | |
| 73700 | <1% | 29 | $3K | |
| 86376 | <1% | 187 | $2K | |
| 90460 | Immunization administration through 18 years of age via any route, first or only component | <1% | 498 | $2K |
| 96360 | Intravenous infusion, hydration; initial, 31 minutes to 1 hour | <1% | 198 | $2K |
| J0561 | Injection, penicillin g benzathine, 100,000 units | <1% | 13 | $2K |
| J1885 | Injection, ketorolac tromethamine, per 15 mg | <1% | 989 | $2K |
| 95251 | <1% | 206 | $2K | |
| 83690 | <1% | 304 | $2K | |
| 0011A | <1% | 324 | $2K | |
| 99386 | <1% | 25 | $2K | |
| 93296 | <1% | 135 | $2K | |
| 93018 | <1% | 332 | $2K | |
| 90474 | <1% | 322 | $2K | |
| 87807 | <1% | 155 | $2K | |
| 73090 | <1% | 189 | $2K | |
| 93017 | <1% | 123 | $2K | |
| 83880 | <1% | 60 | $2K | |
| 95165 | Professional services for the supervision of preparation and provision of antigens for allergen immunotherapy, multiple dose vials | <1% | 16 | $2K |
| 87340 | <1% | 152 | $2K | |
| 77066 | Tomosynthesis, mammo | <1% | 162 | $2K |
| 77080 | <1% | 75 | $2K | |
| 97112 | Therapeutic procedure, each 15 minutes; neuromuscular reeducation of movement, balance, coordination | <1% | 145 | $2K |
| 80076 | <1% | 296 | $2K | |
| 81001 | <1% | 552 | $2K | |
| 94762 | <1% | 104 | $2K | |
| 86431 | <1% | 285 | $2K | |
| 72110 | <1% | 70 | $2K | |
| J0696 | Injection, ceftriaxone sodium, per 250 mg | <1% | 454 | $2K |
| 84702 | <1% | 271 | $2K | |
| 90677 | <1% | 347 | $1K | |
| 99381 | <1% | 29 | $1K | |
| 77063 | Screening digital breast tomosynthesis, bilateral | <1% | 794 | $1K |
| 90480 | <1% | 92 | $1K | |
| 72146 | <1% | 17 | $1K | |
| 69436 | Tympanostomy (requiring insertion of ventilating tube), general anesthesia | <1% | 18 | $1K |
| 83014 | <1% | 156 | $1K | |
| 10060 | <1% | 14 | $1K | |
| J1100 | Injection, dexamethasone sodium phosphate, 1 mg | <1% | 1,062 | $1K |
| 84550 | <1% | 295 | $1K | |
| 93016 | <1% | 123 | $1K | |
| 73000 | <1% | 101 | $1K | |
| 78434 | <1% | 95 | $1K | |
| 99459 | <1% | 86 | $1K | |
| 82950 | <1% | 198 | $1K | |
| 90670 | <1% | 653 | $1K | |
| 83525 | <1% | 109 | $1K | |
| 85018 | <1% | 451 | $1K | |
| 86762 | <1% | 63 | $1K | |
| L3908 | Wrist hand orthosis, wrist extension control cock-up, non molded, prefabricated, off-the-shelf | <1% | 54 | $990.29 |
| 77065 | Tomosynthesis, mammo | <1% | 34 | $989.65 |
| Q9957 | Injection, perflutren lipid microspheres, per ml | <1% | 12 | $977.79 |
| 58301 | <1% | 12 | $917.04 | |
| 82533 | <1% | 54 | $909.31 | |
| 99383 | <1% | 13 | $905.64 | |
| 36416 | <1% | 867 | $853.24 | |
| 97162 | <1% | 28 | $841.10 | |
| 99309 | Subsequent nursing facility care, per day, low to moderate complexity | <1% | 31 | $827.48 |
| 20553 | <1% | 32 | $785.99 | |
| 90832 | Psychotherapy session, about 30 minutes | <1% | 28 | $772.74 |
| 94690 | <1% | 31 | $730.82 | |
| 91322 | <1% | 12 | $729.60 | |
| 29075 | <1% | 16 | $707.24 | |
| G2023 | Specimen collection for severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), any specimen source | <1% | 37 | $700.28 |
| 85014 | <1% | 263 | $680.51 | |
| 64405 | <1% | 19 | $673.05 | |
| J2785 | Injection, regadenoson, 0.1 mg | <1% | 14 | $669.56 |
| J7613 | Albuterol, inhalation solution, fda-approved final product, non-compounded, administered through dme, unit dose, 1 mg | <1% | 427 | $667.44 |
| 94640 | Pressurized or nonpressurized inhalation treatment for acute airway obstruction | <1% | 340 | $659.70 |
| 86803 | <1% | 41 | $656.01 | |
| 87400 | <1% | 77 | $646.63 | |
| 81002 | <1% | 217 | $638.00 | |
| 70491 | <1% | 13 | $634.45 | |
| 86780 | <1% | 60 | $616.50 | |
| 96110 | Developmental screening, with scoring and documentation, per standardized instrument | <1% | 170 | $572.30 |
| 85610 | <1% | 179 | $561.33 | |
| 91200 | <1% | 31 | $546.60 | |
| 96375 | Therapeutic injection; each additional sequential IV push | <1% | 63 | $544.68 |
| 93294 | <1% | 46 | $544.63 | |
| 76817 | Ultrasound, pregnant uterus, real time with image documentation, transvaginal | <1% | 13 | $533.75 |
| 86850 | <1% | 62 | $522.50 | |
| 20611 | <1% | 14 | $516.40 | |
| 76870 | <1% | 14 | $505.12 | |
| J7030 | Infusion, normal saline solution , 1000 cc | <1% | 316 | $494.02 |
| 86200 | <1% | 43 | $484.40 | |
| 87081 | <1% | 159 | $446.61 | |
| 59025 | Fetal non-stress test | <1% | 18 | $444.37 |
| 73560 | <1% | 52 | $434.00 | |
| 64450 | <1% | 19 | $420.38 | |
| 99211 | Office or other outpatient visit for the evaluation and management of an established patient, minimal severity | <1% | 29 | $412.59 |
| 90662 | <1% | 95 | $404.20 | |
| 90935 | Hemodialysis procedure with single evaluation by a physician | <1% | 16 | $383.31 |
| J3420 | Injection, vitamin b-12 cyanocobalamin, up to 1000 mcg | <1% | 554 | $381.13 |
| 90688 | <1% | 346 | $363.98 | |
| 0064A | <1% | 25 | $360.00 | |
| 77002 | <1% | 29 | $358.22 | |
| 93010 | Electrocardiogram, routine ECG with at least 12 leads; interpretation and report only | <1% | 84 | $341.85 |
| 90473 | <1% | 27 | $324.90 | |
| 90673 | <1% | 15 | $309.82 | |
| 99307 | <1% | 54 | $305.20 | |
| 92015 | Determination of refractive state | <1% | 1,017 | $300.09 |
| 0134A | <1% | 36 | $293.28 | |
| 94664 | <1% | 118 | $289.55 | |
| A9552 | Fluorodeoxyglucose f-18 fdg, diagnostic, per study dose, up to 45 millicuries | <1% | 25 | $286.96 |
| 84480 | <1% | 64 | $286.69 | |
| 99457 | <1% | 76 | $280.23 | |
| 90710 | <1% | 413 | $270.15 | |
| 71101 | <1% | 14 | $245.21 | |
| J2550 | Injection, promethazine hcl, up to 50 mg | <1% | 115 | $235.67 |
| 86580 | <1% | 43 | $221.48 | |
| 86900 | <1% | 63 | $220.54 | |
| 82040 | <1% | 51 | $215.66 | |
| 74019 | <1% | 15 | $215.18 | |
| 76882 | <1% | 12 | $200.55 | |
| 84156 | <1% | 55 | $200.18 | |
| 90680 | <1% | 539 | $189.15 | |
| 86901 | <1% | 63 | $187.29 | |
| 90723 | <1% | 491 | $180.08 | |
| 90671 | <1% | 398 | $166.07 | |
| A9575 | Injection, gadoterate meglumine, 0.1 ml | <1% | 424 | $160.84 |
| 73552 | <1% | 14 | $154.94 | |
| 82627 | <1% | 15 | $150.71 | |
| J1200 | Injection, diphenhydramine hcl, up to 50 mg | <1% | 225 | $142.82 |
| 90734 | <1% | 128 | $141.71 | |
| J0702 | Injection, betamethasone acetate 3 mg and betamethasone sodium phosphate 3 mg | <1% | 14 | $133.93 |
| 86706 | <1% | 12 | $114.86 | |
| 86800 | <1% | 12 | $98.41 | |
| 17003 | <1% | 18 | $77.51 | |
| 93325 | <1% | 13 | $73.68 | |
| 86308 | <1% | 14 | $71.35 | |
| G0180 | Physician or allowed practitioner certification for medicare-covered home health services under a home health plan of care (patient not present), including contacts with home health agency and review of reports of patient status required by physicians and allowed practitioners to affirm the initial implementation of the plan of care | <1% | 26 | $68.37 |
| 82565 | <1% | 13 | $65.34 | |
| G0008 | Administration of influenza virus vaccine | <1% | 202 | $51.30 |
| J2405 | Injection, ondansetron hydrochloride, per 1 mg | <1% | 106 | $50.12 |
| 90697 | <1% | 273 | $48.01 | |
| 90633 | <1% | 567 | $36.93 | |
| G0283 | Electrical stimulation (unattended), to one or more areas for indication(s) other than wound care, as part of a therapy plan of care | <1% | 75 | $26.15 |
| 99458 | <1% | 26 | $23.00 | |
| 97022 | <1% | 25 | $19.31 | |
| 90648 | <1% | 715 | $12.00 | |
| 51798 | <1% | 12 | $9.72 | |
| J7620 | Albuterol, up to 2.5 mg and ipratropium bromide, up to 0.5 mg, fda-approved final product, non-compounded, administered through dme | <1% | 45 | $9.22 |
| 90970 | <1% | 13 | $5.89 | |
| 82962 | <1% | 26 | $0.66 | |
| 90696 | <1% | 110 | $0.17 | |
| 90700 | <1% | 80 | $0.13 | |
| 90698 | <1% | 223 | $0.01 | |
| 77062 | 0% | 128 | $0.00 | |
| 90707 | 0% | 12 | $0.00 | |
| 69209 | 0% | 13 | $0.00 | |
| 90681 | 0% | 17 | $0.00 | |
| 90744 | 0% | 39 | $0.00 | |
| 90619 | 0% | 19 | $0.00 | |
| 99024 | 0% | 14 | $0.00 | |
| 1111F | 0% | 15 | $0.00 |
Claims and beneficiary counts add up across code × month rows, so one patient seen every month counts many times. Rows with fewer than 12 claims are suppressed by HHS, so small lines can be missing.
From NPPES
Who's on the registration
Authorized officialHARSTON, JED (DIRECTOR OF MANAGED CARE)
| Provider | Location | Paid |
|---|---|---|
| Central Utah Clinic, P.C. | American Fork, UT | $45K |
Matched on the authorized-official name exactly as entered in NPPES. A common name can match unrelated people.